2018
DOI: 10.1111/all.13638
|View full text |Cite
|
Sign up to set email alerts
|

Allergological workup with half‐dose challenge in iodinated contrast media hypersensitivity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
23
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 13 publications
(23 citation statements)
references
References 9 publications
0
23
0
Order By: Relevance
“…This increased incidence is a concern for doctors and patients as HSR diagnosis implies avoiding ICMs, which are required for radiological examination or treatment of different entities. The evaluation of HSRs to ICMs has been gaining attention over recent years (Brockow et al, 2005;Brockow et al, 2009;Hasdenteufel et al, 2011;Torres et al, 2012;Salas et al, 2013;Lerondeau et al, 2016;Sese et al, 2016;Soria et al, 2019;Trautmann et al, 2019;Brockow, 2020). The allergological work-up not only confirms or excludes the diagnosis but also finds safe alternative ICM.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…This increased incidence is a concern for doctors and patients as HSR diagnosis implies avoiding ICMs, which are required for radiological examination or treatment of different entities. The evaluation of HSRs to ICMs has been gaining attention over recent years (Brockow et al, 2005;Brockow et al, 2009;Hasdenteufel et al, 2011;Torres et al, 2012;Salas et al, 2013;Lerondeau et al, 2016;Sese et al, 2016;Soria et al, 2019;Trautmann et al, 2019;Brockow, 2020). The allergological work-up not only confirms or excludes the diagnosis but also finds safe alternative ICM.…”
Section: Discussionmentioning
confidence: 99%
“…It is based on the clinical history, STs, and DPTs, although their role has not been fully established. The diagnostic sensitivity of STs has been reported to range from less than 5% to more than 90% (Vernassiere et al, 2004;Kvedariene et al, 2006;Trcka et al, 2008;Brockow et al, 2009;Dewachter et al, 2011;Goksel et al, 2011;Torres et al, 2012;Prieto-Garcia et al, 2013;Morales-Cabeza et al, 2017), being its routine use still matter of debate (Brockow et al, 2009;Caimmi et al, 2010;Goksel et al, 2011;Prieto-Garcia et al, 2013;Yoon et al, 2015;Soria et al, 2019). DPT is considered the gold standard for diagnosing HSRs to drugs (Aberer et al, 2003), and, in the case of HSRs to ICMs, it is recommended to be performed with the ICM giving negative results in STs for confirming diagnosis or looking for a safe alternative (Rosado Ingelmo et al, 2016;Brockow, 2020).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Intravenous drug provocation test (DPT) with a skin testenegative contrast agent (ICM or GBCM) has been increasingly described, but it is neither part of routine allergological workup yet nor standardized and validated. 39,59,[61][62][63][64] For fluorescein, conjunctival DPT has been reported as additional diagnostical step when all skin tests were negative. 65 Severe reactions to DPT have been reported, and DPT could cause side effects such as kidney damage when using ICM or nephrogenic systemic fibromatosis when using GBCM.…”
Section: Drug Provocation Testmentioning
confidence: 99%
“…65 Severe reactions to DPT have been reported, and DPT could cause side effects such as kidney damage when using ICM or nephrogenic systemic fibromatosis when using GBCM. 61 Because of its risk of hypersensitivity reactions, DPT should be performed in experienced and well-equipped institutions. Performing DPT may be considered especially in patients after severe anaphylaxis with a skin testenegative alternative contrast medium, because DPT has a higher sensitivity than skin testing alone.…”
Section: Drug Provocation Testmentioning
confidence: 99%